Effect of fludrocortisone in the management of hyponatremia after aneurysmal subarachnoid hemorrhage
- 26 September 2025
- journal article
- research article
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-7
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH) is associated with significant morbidity, particularly related to delayed cerebral ischemia (DCI). Hyponatremia, defined as a serum sodium level < 135 mmol/l, is a common complication of aSAH and is associated with the development of DCI. Fludrocortisone is used to decrease natriuresis and improve hyponatremia, but has failed to demonstrate a reduction in the frequency of cerebral vasospasm or DCI. Using the ProReSHA database, we retrospectively analyzed the impact of fludrocortisone on the development of DCI in patients hospitalized in neurocritical care unit after aSAH and presenting hyponatremia. Two hundred sixteen patients were included, 88 in the fludrocortisone group and 128 in the control group. DCI occurred in 35 (39.8%) patients in the fludrocortisone group and 34 (26.6%) in the control group (p = 0.058). Hyponatremia was significantly deeper in the fludrocortisone group than in the control group (median [interquartile range]: 130 [128–131] vs. 132 [131–133] mmol/l; p < 0.001), and lasted longer (6.0 [4.0–8.3] vs. 3.0 [2.0–5.0] days; p < 0.001). An ancillary analysis stratified according to the etiology of hyponatremia (cerebral salt wasting syndrome or syndrome of inappropriate secretion of antidiuretic hormone) also found no significant difference regarding DCI occurrence (33.3% vs. 44.6%; p = 0.238) but a significantly lower natriuresis in the cerebral salt wasting syndrome group (225 [187–308] vs. 293 [253–359] mmol/d; p = 0.01). Fludrocortisone did not prevent the development of DCI in patients admitted to a neurocritical care unit for an aneurysmal subarachnoid hemorrhage and presenting with hyponatremia. Effect of fludrocortisone in the management of hyponatremia after aneurysmal subarachnoid hemorrhage.Keywords
This publication has 27 references indexed in Scilit:
- Hyponatremia Incidence After Subarachnoid Hemorrhage and Association with Outcomes: Systematic Review and Meta-AnalysisWorld Neurosurgery, 2025
- The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageRevue Neurologique, 2022
- Temporal Relationship between Hyponatremia and Development of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Patients: A Retrospective Observational StudyJournal of Stroke and Cerebrovascular Diseases, 2020
- The Extracranial Consequences of Subarachnoid HemorrhageWorld Neurosurgery, 2018
- Prevention and Treatment of Hyponatremia in Patients with Subarachnoid Hemorrhage: A Systematic ReviewWorld Neurosurgery, 2018
- Impact of Hyponatremia on Morbidity, Mortality, and Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic ReviewWorld Neurosurgery, 2016
- Cerebral Salt Wasting: Pathophysiology, Diagnosis, and TreatmentNeurosurgery Clinics of North America, 2010
- Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhagePituitary, 2009
- Hémorragie sous-arachnoïdienne grave : natrémie et reinAnnales Françaises d'Anesthésie et de Réanimation, 2005
- Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhageAnnals of Neurology, 1990